BioMarin Pharmaceutical Inc.

BMRN · NASDAQ
Analyze with AI
$61.15+$9.20 (+17.71%)
At close:Dec 19, 2025, 9:00 PM UTC
$61.10−$0.05 (−0.08%)
After hours:Dec 20, 2025, 12:59 AM UTC
P/E TTM22.56
P/B TTM1.94
P/S TTM3.8
Dividend Yield0%
EPS$2.69
Beta0.298
Valuation
PEG Ratio-1.07
FCF Yield7.08%
EV / EBITDA14.36
More On Valuation »
Quality
ROIC6.92%
Gross Margin81.32%
Cash Conv. Ratio1.76
More On Quality »
Growth
Revenue 3Y CAGR10.84%
FCF Growth820.51%
More On Growth »
Safety
Net Debt / EBITDA-0.85
Interest Coverage57.53
More On Safety »
Efficiency
Inventory Turnover0.42
Cash Conv. Cycle720.12
More On Efficiency »

BioMarin Pharmaceutical Inc. (BMRN) stock FAQs

Quick answers sourced from live Financial Modeling Prep fundamentals and AlphaPilot portfolio guidance.

What is BioMarin Pharmaceutical Inc. (BMRN) stock price today?

As of Dec 19, 2025, 9:00 PM UTC, BioMarin Pharmaceutical Inc. (BMRN) stock is trading at $61.15. The stock price is quoted in USD and refreshes in real-time throughout the trading day. AlphaPilot provides live market data powered by Financial Modeling Prep's institutional-grade API, ensuring you get accurate and up-to-date BMRN stock quotes for informed trading decisions.

What is BioMarin Pharmaceutical Inc.'s market capitalization?

BioMarin Pharmaceutical Inc. (BMRN) has a market capitalization of approximately $11.7B. Market cap is calculated by multiplying the current share price by the total number of outstanding shares. This valuation metric helps investors compare BioMarin Pharmaceutical Inc.'s size relative to other companies in the USD market. The market cap figure updates automatically as the BMRN stock price changes.

What is the 52-week range for BioMarin Pharmaceutical Inc. stock?

BioMarin Pharmaceutical Inc. (BMRN) stock has traded in a 52-week range of $50.76 — $73.51. The 52-week range shows the highest and lowest prices at which BMRN traded over the past year, helping investors assess price volatility and identify potential support and resistance levels. Comparing the current BioMarin Pharmaceutical Inc. stock price to this range provides context for recent price action.

How much trading volume does BioMarin Pharmaceutical Inc. stock have?

BioMarin Pharmaceutical Inc. (BMRN) stock recently traded approximately 17.1M shares. Trading volume indicates market liquidity and investor interest in BMRN. Higher volume typically suggests active participation and can signal important price movements or news catalysts affecting BioMarin Pharmaceutical Inc. stock.

Does BioMarin Pharmaceutical Inc. pay dividends to shareholders?

Yes, BioMarin Pharmaceutical Inc. (BMRN) currently offers a dividend yield of approximately 0%. Dividend yield is calculated by dividing the company's annual dividend payments by the current stock price, expressed as a percentage. This metric helps income-focused investors evaluate BioMarin Pharmaceutical Inc. stock's potential for generating passive income. Dividend data reflects the trailing twelve months (TTM) of distributions.

What is BioMarin Pharmaceutical Inc.'s intraday price range?

Today, BioMarin Pharmaceutical Inc. (BMRN) stock has traded in a range of $54.44 — $63.89. The intraday range represents the lowest and highest prices reached during the current trading session. Monitoring BMRN's intraday volatility helps traders identify entry and exit points, while comparing it to the 52-week range provides perspective on short-term versus long-term price movements.

Where does AlphaPilot get BioMarin Pharmaceutical Inc. stock data?

AlphaPilot sources real-time BMRN stock quotes, fundamental financial data, and historical price charts for BioMarin Pharmaceutical Inc. from Financial Modeling Prep's institutional-grade API. This enterprise data feed provides live market prices during trading hours, along with comprehensive fundamentals that update after each earnings release, SEC filing, or corporate action. The BioMarin Pharmaceutical Inc. stock summary page combines intraday price movements with key metrics like P/E ratio, market cap, dividend yield, and balance sheet data to give investors a complete view of BMRN stock performance.